APPLICATIONS PUBLISHED 9 FEBRUARY 2005
Published: 1-Feb-2006
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Transdermal delivery system with two superimposed adhesive layers having different affinities to the active substance comprised
Thalos Group 1503743*
Delivery of drug amines through an inhalation route
Alexa Molecular Delivery Corp 1503744*
15625 receptor, a novel g-protein coupled receptor
Millennium Pharmaceuticals 1503745*
Pharmaceutical use of COX-2 inhibitors in angiogenesis-mediated ocular disorders
Novartis 1503746*
Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
Aziende Chimiche Riunite Angelini Francesco 1503747*
Drugs for mitigating taxane-induced neurotoxicity
Bionumerik Pharmaceuticals 1503748*
Methionine aminopeptidase-2 inhibitors and methods of use thereof
Praecis Pharmaceuticals 1503749*
Method for the preparation of matairesinol
Hormos Medical Corp 1503750*
Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures
Novogen Research 1503751*
Use of 8-prenylflavanones for antiangiogenesis therapy and for fibrinolytic therapy
Schering 1503752*
A method for inhibiting platelet aggregation
Merck 1503753*
Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
Yissum Research Development Company, of The Hebrew University of Jerusalem 1503754*
Zonisamide use in obesity and eating disorders
Eisai 1503756*
Epothilone derivative for the treatment of hepatoma and other cancer diseases
Novartis 1503756*
Tyrosine kinase inhibitors
Merck 1503757*
Methods of modulating smooth muscle contractility
SmithKline Beecham 1503758*
Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
The Regents of the University of California 1503759*
Camptothecin derivatives and polymeric conjugates thereof
Enzon 1503760*
Substituted piperazines as melanocortin receptor ligands
Neurocrine Biosciences 1503761*
Novel crystalline forms of gatifloxacin
Teva Pharmaceutical Industries 1503762*
Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
Cragmont Pharmaceuticals 1503764*
5-HT4 receptor antagonists for the treatment of heart failure
Medinnova 1503764*
Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
Davis, Bonnie 1503765*
Compositions and methods for treating emphysema
Aeris Therapeutics 1503766*
Compositions and methods for treatment of vitamin D deficiency
Acologix 1503767*
Inositol pyrophosphates, and methods of use thereof
GMP Oxycell 1503768*
Antibiotic/benzoyl peroxide dispenser
Imaginative Research Associates 1503769*
Sedative materials and treatments
University of Strathclyde 1503771*
Soluble composition containing sporopollenin and the use thereof
Maack, Andreas; Maack, Ines 1503772*
Hepatoprotective activity of 2-P-hydroxybenzoylmussaenosidic acid
Council of Scientific and Industrial Research 1503773*
Fenugreek seed bio-active compositions and methods for extracting same
Technical Sourcing International 1503774*
Formulations useful in the treatment of male and female impotence
Indena 1503775*
Method of enhancing biological activity of plant extracts
E-L Management 1503776*
7-hydroxy chromones as potent antioxidants
Unigen Pharmaceuticals 1503777*
Formulation of a mixture of free-bring flavonoids and flavans as a therapeutic agent
Unigen Pharmaceuticals 1503778*
Methods for slowing senescence and treating and preventing diseases associated with senescence
Voyager Pharmaceutical Corp 1503779*
Androgen-regulated PMEPA1 gene and methods of using the same to inhibit cancer cell growth
Henry M. Jackson Foundation for the Advancement of Military Medicine 1503780*
A combination product comprising melagatran and an anti-arrhythmic oxabispidenes
AstraZeneca 1503782*
A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
AstraZeneca 1503783*
Treatment and inhibition of ocular infections and wounds by CAP37 and CAP37 peptides
Pereira, Heloise; Chodash, James; Callegan, Michelle 1503784*
Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
Schering 1503785*
Compositions and methods for diagnosis and treatment of cardiovascular disorders
Atheromastat 1503787*
Treatment of alpha-galactosidase A deficiency
Transkaryotic Therapeutics 1503788*
